메뉴 건너뛰기




Volumn 17, Issue 1, 2011, Pages

A tool for the economic analysis of mass prophylaxis operations with an application to H1N1 influenza vaccination clinics

Author keywords

cost analysis; mass immunization; vaccination

Indexed keywords

INFLUENZA VACCINE;

EID: 78650846617     PISSN: 10784659     EISSN: None     Source Type: Journal    
DOI: 10.1097/PHH.0b013e3181f87952     Document Type: Article
Times cited : (13)

References (15)
  • 1
    • 78650830341 scopus 로고    scopus 로고
    • Centers for Disease Control and Prevention. CDC estimates of 2009,h1n1 influenza cases, hospitalizations and deaths in the United States, April 2009-April 10, 2010. Cumulative Published May 14, 2010. Accessed June 29
    • Centers for Disease Control and Prevention. CDC estimates of 2009 h1n1 influenza cases, hospitalizations and deaths in the United States, April 2009-April 10, 2010. http://www. cdc.gov/h1n1flu/estimates 2009 h1n1.htm#Table%20 Cumulative. Published May 14, 2010. Accessed June 29, 2010
    • (2010)
  • 2
    • 78650811227 scopus 로고    scopus 로고
    • Centers for Disease Control and Prevention. 2009, H1N1 vaccination campaign planning checklist. Published August 31, 2009. Accessed November 10
    • Centers for Disease Control and Prevention. 2009 H1N1 vaccination campaign planning checklist. gov/H1N1flu/vaccination/statelocal/planning checklist.htm. Published August 31, 2009. Accessed November 10, 2009.
    • (2009)
  • 3
    • 3543096015 scopus 로고    scopus 로고
    • Productivity loss tables (Appendix I)
    • Haddix A, Teutsch S, Corso P, eds, 2nd ed. London: Oxford University Press
    • Grosse S. Productivity loss tables (Appendix I). In: Haddix A, Teutsch S, Corso P, eds. Prevention Effectiveness: A Guide to Decision Analysis and Economic Evaluation. 2nd ed. London: Oxford University Press; 2003:245-257.
    • (2003) Prevention Effectiveness: A Guide to Decision Analysis and Economic Evaluation , pp. 245-257
    • Grosse, S.1
  • 5
    • 78650807829 scopus 로고    scopus 로고
    • Centers for Disease Control and Prevention, Large-scale vaccination clinic output and staffing estimates: An example, Accessed October 9
    • Centers for Disease Control and Prevention. Large-scale vaccination clinic output and staffing estimates: An example. http://www.cdc.gov/h1n1flu/ vaccination/pdf/A-Wortley-H1N1-sample-clinic.pdf. Accessed October 9, 2009.
    • (2009)
  • 6
    • 24144474986 scopus 로고    scopus 로고
    • Apersonnel time-motion study of intranasal influenza vaccination in healthy children
    • Washington ML, Humiston SE, Fauerbach PB, et al.Apersonnel time-motion study of intranasal influenza vaccination in healthy children. Vaccine. 2005;23(40):4879-4885.
    • (2005) Vaccine. , vol.23 , Issue.40 , pp. 4879-4885
    • Washington, M.L.1    Humiston, S.E.2    Fauerbach, P.B.3
  • 7
    • 68349134865 scopus 로고    scopus 로고
    • Evaluating the capability and cost of a mass influenza and pneumococcal vaccination clinic via computer simulation [online published ahead of print June 29, 2009]
    • Washington M. Evaluating the capability and cost of a mass influenza and pneumococcal vaccination clinic via computer simulation [online published ahead of print June 29, 2009]. Med Decis Making. 2009;29(4):414-423.
    • (2009) Med Decis Making. , vol.29 , Issue.4 , pp. 414-423
    • Washington, M.1
  • 8
    • 0034605496 scopus 로고    scopus 로고
    • Effectiveness and cost-benefit of influenza vaccination of healthy working adults: A randomized controlled trial
    • Bridges CB, Thompson WW, Meltzer MI, et al. Effectiveness and cost-benefit of influenza vaccination of healthy working adults: A randomized controlled trial. JAMA. 2000;284(13):1655-1663.
    • (2000) JAMA , vol.284 , Issue.13 , pp. 1655-1663
    • Bridges, C.B.1    Thompson, W.W.2    Meltzer, M.I.3
  • 9
    • 85058201506 scopus 로고    scopus 로고
    • Cost benefit of influenza vaccination in healthy, working adults: An economic analysis based on the results of a clinical trial of trivalent live attenuated influenza virus vaccine
    • Nichol KL, Mallon KP, Mendelman PM. Cost benefit of influenza vaccination in healthy, working adults: An economic analysis based on the results of a clinical trial of trivalent live attenuated influenza virus vaccine. Vaccine. 2003;21(17- 18):2207-2217.
    • (2003) Vaccine. , vol.21 , Issue.17-18 , pp. 2207-2217
    • Nichol, K.L.1    Mallon, K.P.2    Mendelman, P.M.3
  • 10
    • 38349002638 scopus 로고    scopus 로고
    • Non-traditional settings for influenza vaccination of adults: Costs and cost effectiveness
    • Prosser LA, O'Brien MA, Molinari NA, et al. Non-traditional settings for influenza vaccination of adults: Costs and cost effectiveness. Pharmacoeconomics. 2008;26(2):163-178.
    • (2008) Pharmacoeconomics. , vol.26 , Issue.2 , pp. 163-178
    • Prosser, L.A.1    O'Brien, M.A.2    Molinari, N.A.3
  • 11
    • 78650847097 scopus 로고    scopus 로고
    • Bureau of Economic Analysis. National economic accounts. Table 1.1.4. Price indexes for gross domestic product. Accessed August 20
    • Bureau of Economic Analysis. National economic accounts. Table 1.1.4. Price indexes for gross domestic product. http://www.bea.gov/national/nipaweb/ TableView.asp?SelectedTable=4&ViewSeries=NO&Java=no&Request3 Place=N&3Place=N&FromView=YES&Freq=Year&FirstYear= 2003&LastYear=2008&3Place=N&Update=Update&JavaBox=no. Accessed August 20, 2009.
    • (2009)
  • 12
    • 10444273965 scopus 로고    scopus 로고
    • Estimating medical practice expenses fromadministering adult influenza vaccinations
    • Coleman MS, Fontanesi J, Meltzer MI, et al. Estimating medical practice expenses fromadministering adult influenza vaccinations. Vaccine. 2005;23(7):915-923.
    • (2005) Vaccine. , vol.23 , Issue.7 , pp. 915-923
    • Coleman, M.S.1    Fontanesi, J.2    Meltzer, M.I.3
  • 13
    • 35548953159 scopus 로고    scopus 로고
    • Cost-effectiveness of live-attenuated influenza vaccine, trivalent in preventing influenza in young children attending day-care centers
    • Hibbert CL, PiedraPA, McLaurin KK, et al. Cost-effectiveness of live-attenuated influenza vaccine, trivalent in preventing influenza in young children attending day-care centers. Vaccine. 2007;25:8010-8020.
    • (2007) Vaccine. , vol.25 , pp. 8010-8020
    • Hibbert, C.L.1    Piedra, P.A.2    McLaurin, K.K.3
  • 14
    • 76149107831 scopus 로고    scopus 로고
    • Statewide school-located influenza vaccination program for children 5-13 years of age, Hawaii, USA
    • Effler PV, Chu C, He H, et al. Statewide school-located influenza vaccination program for children 5-13 years of age, Hawaii, USA. Emerg Infect Dis. 2010;16(2):244-250.
    • (2010) Emerg Infect Dis. , vol.16 , Issue.2 , pp. 244-250
    • Effler, P.V.1    Chu, C.2    He, H.3
  • 15
    • 77954927618 scopus 로고    scopus 로고
    • Strategies for implementing school-located influenza vaccination of children: A systematic literature review
    • Cawley J, Hull HF, Rousculp MD. Strategies for implementing school-located influenza vaccination of children: A systematic literature review. J School Health. 2010;80(4):167-175
    • (2010) J School Health. , vol.80 , Issue.4 , pp. 167-175
    • Cawley, J.1    Hull, H.F.2    Rousculp, M.D.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.